Jeremie Soriano – from Dwarf to Giant

Jeremie Soriano – from Dwarf to Giant

For Part 1 of Jeremie’s story, click here.

I just want to share my rare disease story today! I used to be a theater actor and a performer on stage. My first role as an actor was a “dwarf” on a fantasy play way back 2017 and just this year 8 years after I was given a role for a fantasy play but this time it was a giant. I portrayed the character of “Dillon” a “God of Faith. 

Instead of crying and laughing about how big I am right now, I see it in a positive way. Nothing changes aside from my physical appearance. It is still me, the same as who I am a few years back prior my Acromegaly diagnosis. I can still do things that I love, I still do things that make me happy. Most of the people that I am having conversations with don’t recognize that I am diagnosed with a rare condition, unless I open up with them about it.  I usually don’t bring up acromegaly. It is because I don’t want them to see my illness, I want them to see the things that I am capable of doing. 

 

I want them to see that even Acromegaly patients are also just like normal people. That’s what I always told my fellow Acromegaly patients here in our country, the Philippines. In fact, these past few months before the year ended, I received some news that my IGF-1 is getting higher despite taking Cabergoline. It was higher than before, but I guess our journey as an Acromegaly patient is like a rollercoaster. I still think positively-, I just go with the flow, and I just live my life as it was before my diagnosis. I hope and pray for a better health in the upcoming years!

 

Source: Jeremie Soriano

To learn more about Jeremie and his journey with Acromegaly and life in the Philippines, go to support and him his Facebook group at (20+) Acromegaly – Philippines | Facebook

PW Collaborator

Our mission is to amplify the rare condition voice. One of the ways we achieve that is through collaborations across the community, from patients and caregivers to industry leaders in treatment research and development. To learn more, click here.